Apr 11 (Reuters)-
Chordia Therapeutics Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Feb 28, 2025 Feb 29, 2024 Aug 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Operating loss 996 mln loss 809 mln loss 2.43
Recurring loss 975 mln loss 801 mln loss 2.38
Net loss 976 mln loss 802 mln loss 2.38
EPS loss 14.31 yen loss 14.22 yen loss 35.17 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Chordia Therapeutics Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=190A.T